Cold Spring Harbor Asia- Alzheimer's Disease: Fundamentals and Treatments
CONFERENCE 2024-04-08 00:00:00-2024-04-12 00:00:00 Suzhou, China 08 – 12 April 2024 View Conference Website 0
330732 RESULTS
CONFERENCE 2024-04-08 00:00:00-2024-04-12 00:00:00 Suzhou, China 08 – 12 April 2024 View Conference Website 0
CONFERENCE 2023-10-20 00:00:00-2023-10-23 00:00:00 Tucson, Arizona 20 – 23 October 2023 View Conference Website 0
CONFERENCE 2023-08-28 00:00:00-2023-09-01 00:00:00 Tromsø, Norway 28 August – 01 September 2023 View Conference Website 0
COMMENT GFAP is gaining more and more interest as a biomarker for Alzheimer’s disease and other dementias. While previous studies already indicated the prognostic value of GFAP, e.g., in cognitively unimpaired individuals in memory clinics (Verberk et al., 2021;
CMI MF Dr. Nerisanu Remus-OctavianUcea de Jos, Romania
PAPER Bauer CE, Zachariou V, Sudduth TL, Van Eldik LJ, Jicha GA, Nelson PT, Wilcock DM, Gold BT
PAPER Gilardone G, Longo C, Papagno C
PAPER Liu N, Yuan Z, Chen Y, Liu C, Wang L
PAPER Healthcare Engineering JO
PAPER Sepulveda-Falla D
PAPER
PAPER
PAPER Luca A, Donzuso G, Mostile G, Terranova R, Cicero CE, Nicoletti A, Zappia M
PAPER Su Y, Wang D, Liu N, Yang J, Sun R, Zhang Z
PAPER Arizaca Maquera KA, Welden JR, Margvelani G, Miranda Sardón SC, Hart S, Robil N, Hernandez AG, de la Grange P, Nelson PT, Stamm S